Active Ingredient(S)
Salicylic acid 0.75%
Acne Treatment Pads Patch
FDA Label NDC 87308-001
Full FDA labeling including Indications, Dosage, Usage, and Precautions
Structured Product Label
The following Structured Product Label (SPL) was submitted to the FDA by Shenzhen Hengdasheng Technology Co., Ltd for the product Acne Treatment Pads (NDC 87308-001). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredient(s), purpose, use, warnings, do not use, otc - when using, otc - stop use, otc - keep out of reach of children, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Label Section Quick Index
Purpose
Acne Treatment
Use
Helps reduce acne blemishes
Helps keep pores clear
Warnings
For external use only
Do Not Use
If you are allergic to this product, please do not use it.
Otc - When Using
Skin irritation and dryness may occur if you use anothertopical acne product at the same time.Stop use and aska doctor if irritation becomes severe
Otc - Stop Use
If there is irritation, stop using it immediately.
Otc - Keep Out Of Reach Of Children
If swallowed, get medical help or contact a PoisonControl Center right away.
Directions
Clean and dry the affected area before use.
Apply the patch to the affected area with dry hands.
Gently press to ensure adhesion.
Remove the patch after up to 6-8 hours of use.
Other Information
Store at room temperature
Protect from excessive heat and humidity
Inactive Ingredients
Water, Sodium Hyaluronate, Hydroxyethyl Cellulose, Arginine,Azelaic Acid, Pvp, Trehalose, Niacinamide, DipotassiumGlycyrrhizate, Peg-8, Madecassoside, Centella Asiatica extract,Butylene Glycol, Glycine Soja (soybean) Seed Extract,Melaleuca alternifolia(Tea Tree) Leaf Oil,Quaternium-73
Package Label - Principal Display Panel
Undefined (Label)
* Please review the disclaimer below.
